Treatment of Post-COVID-19 Telogen Effluvium

The document details a case study of a 34-year-old female patient who experienced post-COVID-19 telogen effluvium, a condition of increased hair loss, particularly in the bitemporal region, which began three months after her COVID-19 infection. The study attributes the hair loss to fever and stress related to COVID-19, with no significant abnormalities found in laboratory tests. The patient was successfully treated with nightly applications of topical Minoxidil 5% for five months, leading to reduced hair loss. The study concludes that topical treatments like Minoxidil are effective for hair loss due to post-COVID-19 telogen effluvium and highlights the importance of addressing the underlying cause.